How Do You Spell DIMETHYL TRIAZENO IMIDAZOLE CARBOXAMIDE?

Pronunciation: [dˈa͡ɪmθa͡ɪl tɹˌa͡ɪɐzˈiːnə͡ʊ ɪmˈɪdɐzˌə͡ʊl kˈɑːbəksˌama͡ɪd] (IPA)

The word "Dimethyl Triazeno Imidazole Carboxamide" may seem like a mouthful, but its spelling can be broken down by understanding the International Phonetic Alphabet (IPA) symbols. "Dimethyl" is pronounced /daɪˈmɛθəl/, "triazeno" as /traɪˈæzɪnoʊ/, "imidazole" as /ɪˈmɪdəˌzoʊl/, and "carboxamide" as /kɑrbɑksˈæmɪd/. By breaking down each portion of the word using IPA symbols, it becomes easier to understand, spell and helps in the correct pronunciation. This word is commonly used in pharmacology and chemistry.

DIMETHYL TRIAZENO IMIDAZOLE CARBOXAMIDE Meaning and Definition

  1. Dimethyl Triazeno Imidazole Carboxamide (DTIC) is a term that refers to a chemical compound used in medicine as an antineoplastic agent, primarily in the treatment of certain types of skin cancer known as malignant melanoma.

    Chemically, DTIC is classified as an imidazole derivative and has the formula C8H10N6O. This compound consists of a triazene group (connected to three nitrogen atoms in a cyclic structure) attached to an imidazole ring, which in turn is attached to a carboxamide functional group. The presence of the carboxamide group enhances the drug's solubility and stability, allowing it to be readily administered intravenously.

    DTIC is primarily administered as a prodrug, meaning that it is converted into its active form in the body. Upon administration, it is metabolized in the liver to dimethyltriazenoimidazolecarboxamide diazohydroxide, which acts as an alkylating agent. This active metabolite interacts with DNA molecules within cancer cells, interrupting their replication and inducing cell death.

    Due to its specific mechanism of action, DTIC is used specifically for the treatment of metastatic melanoma, a particularly aggressive form of skin cancer. However, its success as a treatment modality has been limited, and it is often used in combination with other chemotherapeutic agents or immunotherapies to enhance its efficacy. Adverse effects associated with DTIC administration include nausea, vomiting, myelosuppression (decreased production of blood cells), and hepatotoxicity (liver damage).

    In summary, DTIC is an antineoplastic agent commonly used in the treatment of malignant melanoma. It functions by inhibiting DNA synthesis and

Common Misspellings for DIMETHYL TRIAZENO IMIDAZOLE CARBOXAMIDE

  • simethyl triazeno imidazole carboxamide
  • ximethyl triazeno imidazole carboxamide
  • cimethyl triazeno imidazole carboxamide
  • fimethyl triazeno imidazole carboxamide
  • rimethyl triazeno imidazole carboxamide
  • eimethyl triazeno imidazole carboxamide
  • dumethyl triazeno imidazole carboxamide
  • djmethyl triazeno imidazole carboxamide
  • dkmethyl triazeno imidazole carboxamide
  • domethyl triazeno imidazole carboxamide
  • d9methyl triazeno imidazole carboxamide
  • d8methyl triazeno imidazole carboxamide
  • dinethyl triazeno imidazole carboxamide
  • dikethyl triazeno imidazole carboxamide
  • dijethyl triazeno imidazole carboxamide
  • dimwthyl triazeno imidazole carboxamide
  • dimsthyl triazeno imidazole carboxamide
  • dimdthyl triazeno imidazole carboxamide
  • dimrthyl triazeno imidazole carboxamide
  • dim4thyl triazeno imidazole carboxamide

Infographic

Add the infographic to your website: